Plainsboro, NJ, United States of America

Udaykumar Jain

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Celgene Corporation. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Udaykumar Jain. Retrieved from https://idiyas.com/inventor/udaykumar-jain

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.2

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Udaykumar Jain: Innovator in Pharmaceutical Formulations

Introduction

Udaykumar Jain is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, holding 2 patents that reflect his innovative work.

Latest Patents

His latest patents include formulations and processes related to solid forms comprising (S)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile and salts thereof. These patents provide detailed methodologies for using these compositions effectively in various applications.

Career Highlights

Udaykumar Jain is currently associated with Celgene Corporation, where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on creating innovative solutions that enhance drug formulations and delivery.

Collaborations

He collaborates with esteemed colleagues such as Lianfeng Huang and Hon-Wah Man, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Udaykumar Jain's contributions to pharmaceutical formulations exemplify the impact of dedicated inventors in advancing medical science. His patents and ongoing work at Celgene Corporation highlight his commitment to innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…